Invasive intraductal papillary mucinous neoplasms of the pancreas: relationships between mural nodules detected on thin-section contrast-enhanced MDCT and invasive components
- 87 Downloads
To elucidate the relationships between mural nodules (MNs) and invasive components in patients with invasive intraductal papillary mucinous neoplasm (IPMN) on the basis of thin-section contrast-enhanced multidetector CT (CE-MDCT) and pathologic findings.
This retrospective study included 28 patients with surgically confirmed invasive IPMN. Two radiologists independently evaluated the thin-section (1-mm section thickness, no overlap) triple-phase CE-MDCT images for MNs, invasive components, and the continuity between them using a five-point scale (confidence scores of 1–3 as negative, 4 and 5 as positive). Kappa statistic was used to evaluate interobserver agreement. The CE-MDCT findings were correlated with pathologic findings.
Interobserver agreement was good or excellent. MNs consisting of tumor cells were recognized in 12 (42.9%) of 28 patients with no discrepancy between the two radiologists. Invasive components were detected in 85.7% and 82.1% in the pancreatic parenchymal phase for radiologist 1 and 2, respectively, and recognized as hypoattenuating areas. Pathologic continuities between MNs and invasive components were confirmed in five (41.7%) of 12 patients with MNs and these were detected on CE-MDCT. When combined seven patients without continuities between MNs and invasive components and 16 patients without MNs, the invasive components pathologically derived from non-nodular low-height papillary epithelium in 23 (82.1%) of 28 patients.
The invasive components derived more often from low-height papillary epithelium without MN appearance on CE-MDCT than from MN. Careful attention should be paid to the existence of an invasive component even in the absence of an enhancing MN.
KeywordsPancreatic neoplasms Multidetector computed tomography Pancreatic ducts
Multidetector computed tomography
Intraductal papillary mucinous neoplasm
Main pancreatic duct
- 3.Adsay, N.V., Fukushima, N, Furukawa, T. et al., Intraductal neoplasms of the pancreas. In: Bosman FT, Carneiro F, Hruban RH, Theise ND, editors. (2010) WHO classification of tumours of the digestive system: Lyon: WHO Press. pp 304-313.Google Scholar
- 4.Doi R, Fujimoto K, Wada M, Imamura M (2002) Surgical management of intraductal papillary mucinous tumor of the pancreas. Surgery 132:80-85.Google Scholar
- 15.Nakagawa A, Yamaguchi T, Ohtsuka M, et al. (2009) Usefulness of multidetector computed tomography for detecting protruding lesions in intraductal papillary mucinous neoplasm of the pancreas in comparison with single-detector computed tomography and endoscopic ultrasonography. Pancreas 38:131-136.CrossRefGoogle Scholar
- 16.Choi SY, Kim JH, Yu MH, Eun HW, Lee HK, Han JK (2017) Diagnostic performance and imaging features for predicting the malignant potential of intraductal papillary mucinous neoplasm of the pancreas: a comparison of EUS, contrast-enhanced CT and MRI. Abdom Radiol (NY) 42:1449-1458.CrossRefGoogle Scholar
- 25.Koshita S, Fujita N, Noda Y et al. (2015) Invasive carcinoma derived from "flat type" branch duct intraductal papillary mucinous neoplasms of the pancreas: impact of classification according to the height of mural nodule on endoscopic ultrasonography. J Hepatobiliary Pancreat Sci 22:301-309.CrossRefGoogle Scholar
- 29.Vege SS, Ziring B, Jain R, Moayyedi P (2015); Clinical Guidelines Committee; American Gastroenterology Association. American gastroenterological association institute guideline on the diagnosis and management of asymptomatic neoplastic pancreatic cysts. Gastroenterology 148:819-822.Google Scholar